Real-world results of Zeiss selective laser trabeculoplasty in South African adult glaucoma and ocular hypertension patients.
- Conditions
- Eye Diseases
- Registration Number
- PACTR202303599487772
- Lead Sponsor
- not applicable
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 200
Patients with primary open angle glaucoma or ocular hypertension.
Patients who had the SLT procedure in the period from May to December 2022
Must have at least 3 months follow up after SLT.
Patients who are on one or more topical intraocular pressure (IOP) lowering agent prior to SLT treatment, or treatment naïve patients who received SLT as primary intervention prior to commencing IOP treatment.
Patients who did not attend at least a 3-month follow-up after SLT.
Patients with poorly controlled glaucoma who required surgery as primary intervention at the time of assessment, even though they may have still received SLT.
Patients who had any ocular surgery during the period of the chart review.
Previous successful or failed glaucoma surgery performed less than a year before the SLT procedure.
Patients who had previous SLT laser.
Abnormal angle anatomy that may have a degree of combined open and closed angle glaucoma.
Anterior chamber angle Schaffer grade 1 or 2.
Congenital glaucoma, neovascular glaucoma or uveitic glaucoma.
Patients under the age of 18.
Pregnancy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method